Icon

ANGIOMAX RTU (nda211215)- (250MG/50ML (5MG/ML))

BIVALIRUDIN MAIA PHARMS INC
250MG/50ML (5MG/ML)
No Yes
2039-May-20 Expired
None None
None No
ANGIOMAX RTU is a direct thrombin inhibitor indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI), including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
0 0 0
Total Other Developers None
Drugs with Suitability No
250MG/50ML (5MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.